Ribupatide TFA is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Ribupatide TFA can be studied in antidiabetic research[1].
Molecular Weight:
4907.48 (free base)
Purity:
99.75
Formula:
C229H346N48O71.xC2HF3O2
Target:
GLP Receptor,Insulin Receptor
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted